HIV viral dynamics

AIDS, Supplement

Volumn 10, Issue 3, 1996, Pages

  Coffin, John M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral therapy; Drug resistance; HIV steady state; Modelling; Mutation; Virus load

Indexed keywords

CELL DEATH; CONFERENCE PAPER; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; VIRUS; VIRUS REPLICATION;

ANTIVIRAL AGENTS; HIV; HIV INFECTIONS; HUMANS; VARIATION (GENETICS); VIRAL LOAD; VIRUS REPLICATION;

EID: 0029803480     PISSN: 13502840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Pantaleo G, Graziosi C, Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993, 328:327-335.
2. Kappes JC, Saag MS, Shaw GM, et al.: Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD UIV-1 p24 antigen and viral RNA (QC-PCR) assays compared. J Acquir Immune Defic Syndr 1995, 10:139-149.
3. Meyerhans A, Cheynier R, Albert J, et al.: Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989, 58:901-910.
4. Myers G, Pavlakis GN: Evolutionary potential of complex retroviruses. In The Retroviridae. Edited by Levy J. New York: Plenum Press; 1992:51-106.
5. Saag MS, Hahn BH, Gibbons J, et al.: Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 1988, 334:440-444.
6. Burns DPW, Desrosiers RC: Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol 1991, 65:1843-1854.
7. Coffin JM: HIV replication dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995, 267:483-488.
8. Embretson J, Supancic M, Ribas JL, et al.: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362:359-362.
9. Pantaleo G, Graziosi C, Demarest JF, et al.: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-359.
10. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature 1995, 373:123-126.
11. Wei X, Ghosh S, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
12. Schuurmann R, Nijhuis M, van Leeuwen R, et al.: Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine. J Infect Dis 1995, 171:1411-1419.
13. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586.
14. Nowak MA, Anderson RM, McLean AR, Wolfs TFW, Goudsmit J, May RM: Antigenic diversity thresholds and the development of AIDS. Science 1991, 254:963-969.
15. McLean AR, Frost SDW: Zidovudine and HIV: mathematical models of within-host population dynamics. Rev Med Virol 1995, 5:141-147.
16. Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
17. Mansky LM, Temin HM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995, 69:5087-5094.
18. Larder BA, Kemp SD, Harrigan PR: Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 1995, 269:696-699.
19. Condra JH, Schleiff WA, Blahy OM, et al.: In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 1995, 374:569-571.